We are closely monitoring the development of COVID-19, specifically in relation to our day to day working activities. We are guided by UK Government advice and have special provisions in place at our Development Centre to resume activities. Our Manufacturing Centre continues to deliver ATMPs to patients.

If you have any further questions, please contact info@ct.catapult.org.uk

Cell and Gene Therapy Catapult
Whether you're at the very start of your research, looking to manufacture therapies, or need regulatory support, we can help.
How we work with you

We have the infrastructure and a team of specialists across the cell and gene therapy life cycle, who will work with you when you need us, to enable you to get the best possible results. We have a range of approaches that can help tackle the challenges you might face in the development of cell and gene therapies. We’ll work with you to accelerate your projects, helping your cell and gene therapies to be safer, more effective, scalable and affordable. We make it our job to stay at the forefront of the latest innovations in cell and gene therapies, so that we're ready to help, whenever you might need us.

Watch this video

About Cell and Gene Therapy Catapult - Interview with CEO Keith Thompson

Who we work with

Latest event

21 Jul
Tue 09:00

This year's Bioprocessing Summit Europe takes virtually this year. The theme of this year's summit is 'Practical solutions for today's bioprocessing challenges'.

Discover who we are